209 related articles for article (PubMed ID: 36709912)
1. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages.
Masuda Y; Nakayama Y; Shimizu R; Naito K; Miyamoto E; Tanaka A; Konishi M
Life Sci; 2023 Mar; 317():121453. PubMed ID: 36709912
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
[TBL] [Abstract][Full Text] [Related]
3. Maturation of dendritic cells by maitake α-glucan enhances anti-cancer effect of dendritic cell vaccination.
Masuda Y; Nakayama Y; Mukae T; Tanaka A; Naito K; Konishi M
Int Immunopharmacol; 2019 Feb; 67():408-416. PubMed ID: 30586664
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide isolated from
Li X; Ruan Q; Yang W; Tian H; Wu N; Qadir J; Wang J; Hu H; Liu Y; Cai M; Yang BB; Xie Y; Wu Q
Int J Biol Sci; 2024; 20(2):664-679. PubMed ID: 38169590
[TBL] [Abstract][Full Text] [Related]
5. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
[TBL] [Abstract][Full Text] [Related]
6. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
7. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
9. Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells.
Lee A; Park H; Lim S; Lim J; Koh J; Jeon YK; Yang Y; Lee MS; Lim JS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627143
[TBL] [Abstract][Full Text] [Related]
10. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
Lim HX; Choi S; Cho D; Kim TS
Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
[TBL] [Abstract][Full Text] [Related]
11. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
[TBL] [Abstract][Full Text] [Related]
12. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ-Induced Myeloid-Derived Suppressor Cells Aggravate Kidney Ischemia-Reperfusion Injury by Regulating Innate Immune Cells.
Ji J; Zhuang Y; Lin Z; Jiang Y; Wang W; Zhang X
Nephron; 2022; 146(1):99-109. PubMed ID: 34569551
[TBL] [Abstract][Full Text] [Related]
14. TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage.
Deng Y; Yang J; Qian J; Liu R; Huang E; Wang Y; Luo F; Chu Y
Mol Immunol; 2019 Aug; 112():266-273. PubMed ID: 31212097
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.
Xie Z; Ikegami T; Ago Y; Okada N; Tachibana M
Oncoimmunology; 2020; 9(1):1734268. PubMed ID: 32158627
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells.
Shime H; Maruyama A; Yoshida S; Takeda Y; Matsumoto M; Seya T
Oncoimmunology; 2017; 7(1):e1373231. PubMed ID: 29296526
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer.
Liang Y; Wang W; Zhu X; Yu M; Zhou C
Sci Rep; 2022 Jun; 12(1):9619. PubMed ID: 35688951
[TBL] [Abstract][Full Text] [Related]
19. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
[TBL] [Abstract][Full Text] [Related]
20. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
Kodama N; Komuta K; Nanba H
J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]